Ophthalmology Doctors in Norman, OK Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Harold Jackson Woodward Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2201 Mckown Dr, #1, Norman, OK 73072 Phone: 405-329-5613    Fax: 405-360-7747

Joshua Trent Powell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 816 24th Ave Nw, Norman, OK 73069 Phone: 405-286-3937    Fax: 405-701-8407

Robert Daniel Bales, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 809 N Findlay Ave, Suite 105, Norman, OK 73071 Phone: 405-701-1122    Fax: 405-701-1151

Dr. Joel C Razook, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2300 36th Ave Nw, Suite 110, Norman, OK 73072 Phone: 405-579-7664    Fax: 405-321-3193

Jason Vinh Nguyen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3151 W Tecumseh Rd Ste 230, Norman, OK 73072 Phone: 888-323-3937

Dr. Kimberly Marie Wise, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2201 Mckown Dr, Norman, OK 73072 Phone: 405-329-5613    Fax: 405-360-7747

News Archive

Interdisciplinary project explores the phenomenon of so-called "superspreaders"

Scientists from the Departments of Physics, Biomedical Sciences and Process Engineering at Otto von Guericke University Magdeburg are in the process of analyzing the emergence and spread of infectious air bubbles in our breath, known as aerosols, using tissue cultivations and artificially-produced, virus-filled suspended particles.

Study explores whether way of expressing condolences should be standardised among oncologists

The results of a new survey published in ecancermedicalscience indicate that a majority of oncology professionals believe that writing condolence letters to the families of deceased patients is an important component of cancer palliative care.

Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.

Scientists produce SR-3306 compound to protect brain cells from Parkinson's disease

Scientists from the Florida campus of The Scripps Research Institute have produced the first known compound to show significant effectiveness in protecting brain cells directly affected by Parkinson's disease, a progressive and fatal neurodegenerative disorder.

Public health and environment at risk: Large tobacco company influences EU policymaking

One of the world's largest tobacco companies has been instrumental in pushing through fundamental changes to EU policymaking, researchers from the University of Bath have found.

Read more Medical News

› Verified 1 days ago